- Home
- ACIC vs OABI Comparison
ACIC vs OABI Comparison
Compare ACIC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIC
- OABI
- Stock Information
- Founded
- ACIC 1999
- OABI 2012
- Country
- ACIC United States
- OABI United States
- Employees
- ACIC N/A
- OABI N/A
- Industry
- ACIC Property-Casualty Insurers
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- ACIC Finance
- OABI Health Care
- Exchange
- ACIC Nasdaq
- OABI Nasdaq
- Market Cap
- ACIC 556.0M
- OABI 236.1M
- IPO Year
- ACIC N/A
- OABI N/A
- Fundamental
- Price
- ACIC $10.77
- OABI $2.04
- Analyst Decision
- ACIC Buy
- OABI Strong Buy
- Analyst Count
- ACIC 1
- OABI 3
- Target Price
- ACIC $16.00
- OABI $7.00
- AVG Volume (30 Days)
- ACIC 242.2K
- OABI 700.7K
- Earning Date
- ACIC 08-06-2025
- OABI 08-07-2025
- Dividend Yield
- ACIC 4.64%
- OABI N/A
- EPS Growth
- ACIC 3.21
- OABI N/A
- EPS
- ACIC 1.49
- OABI N/A
- Revenue
- ACIC $302,261,000.00
- OABI $26,744,000.00
- Revenue This Year
- ACIC N/A
- OABI N/A
- Revenue Next Year
- ACIC $37.63
- OABI $45.02
- P/E Ratio
- ACIC $7.32
- OABI N/A
- Revenue Growth
- ACIC 23.92
- OABI 27.07
- 52 Week Low
- ACIC $8.82
- OABI $1.22
- 52 Week High
- ACIC $15.08
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- ACIC 47.93
- OABI 63.58
- Support Level
- ACIC $10.64
- OABI $1.79
- Resistance Level
- ACIC $11.16
- OABI $2.30
- Average True Range (ATR)
- ACIC 0.26
- OABI 0.13
- MACD
- ACIC 0.04
- OABI 0.04
- Stochastic Oscillator
- ACIC 51.58
- OABI 64.86
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.